Dr. Srinivas Rao, Co-Founder and CEO of atai, added, “This agreement strengthens our DMT patent portfolio and enables us to ...

Agreement allows Andelyn to use Stanton Lab CNS capsids to perform R&D services for clients developing gene therapies.

AstraZeneca 4Q Revenues: $14.9 billion (+24%) 4Q Earnings: $1.5 billion (+56%) FY Revenues: $54.1 billion (+18%) FY Earnings: $7.0 billion (+18%) Comments: Oncology sales were $22.4 billion, up 21%.

Tiziana Life Sciences Ltd., a biotechnology company pioneering breakthrough immunomodulation therapies, has entered a ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel ...

Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has ...

ACG Capsules, a capsule manufacturer, has introduced fully vegan printed capsules.

Eleva, a pioneer in unlocking difficult-to-produce biologics, has appointed Dr. Martin Bauer, MD, as its new Chief Medical ...

The U.S. Food and Drug Administration (FDA) has accepted for filing PTC Therapeutics’ New Drug Application (NDA) for ...

Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, ...

Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), has signed a multi-year ...

Brexogen, a biotechnology company specializing in exosome-based therapeutics, has signed a technology transfer and licensing ...